We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

49 hedge funds and large institutions have $138M invested in Twist Bioscience in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

4% more funds holding

Funds holding: 47 → 49 (+2)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

3% less capital invested

Capital invested by funds: $142M → $138M (-$3.79M)

1.36% less ownership

Funds ownership: 22.79% → 21.43% (-1.4%)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
8
Increased
16
Reduced
15
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$2.1M
2
EA
Emerald Advisers
Pennsylvania
+$1.59M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$1.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$944K
5
Ameriprise
Ameriprise
Minnesota
+$730K

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$5.07M
2
IP
Intellectus Partners
California
-$4.08M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$1.81M
4
Norges Bank
Norges Bank
Norway
-$1.16M
5
LCM
Landscape Capital Management
New Jersey
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$27.6M – – –
JP Morgan Chase
2
JP Morgan Chase
New York
$24.4M +$2.1M +93,144 +10%
CAM
3
Cormorant Asset Management
Massachusetts
$16.4M – – –
Federated Hermes
4
Federated Hermes
Pennsylvania
$12.2M -$1.81M -80,305 -13%
A
5
Apoletto
British Virgin Islands
$10.5M – – –
BlackRock
6
BlackRock
New York
$8.44M +$614K +27,162 +8%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.8M +$944K +41,766 +20%
EA
8
Emerald Advisers
Pennsylvania
$5.45M +$1.59M +70,391 +43%
EMFAT
9
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.75M +$1.57M +69,696 +52%
AG
10
Artal Group
Luxembourg
$3.48M – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.04M +$304K +13,470 +18%
Northern Trust
12
Northern Trust
Illinois
$1.73M +$114K +5,049 +7%
SSA
13
Schonfeld Strategic Advisors
New York
$1.73M -$599K -26,500 -26%
FCMI
14
Foresite Capital Management II
California
$1.69M – – –
Ameriprise
15
Ameriprise
Minnesota
$1.68M +$730K +32,321 +80%
Victory Capital Management
16
Victory Capital Management
Texas
$1.68M -$36.8K -1,630 -2%
State Street
17
State Street
Massachusetts
$1.54M +$438K +19,382 +41%
DCM
18
Driehaus Capital Management
Illinois
$1.46M -$371K -16,406 -21%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.09M +$44.9K +1,989 +4%
Charles Schwab
20
Charles Schwab
California
$727K +$100K +4,437 +16%
Barclays
21
Barclays
United Kingdom
$718K +$692K +30,610 +8,898%
ACM
22
Asymmetry Capital Management
California
$550K +$536K +23,733 New
BM
23
Brandywine Managers
Delaware
$463K – – –
Bank of New York Mellon
24
Bank of New York Mellon
New York
$439K +$428K +18,931 New
TA
25
Teachers Advisors
New York
$248K +$242K +10,695 New
1
2 3

TWST Hedge Fund Activity: Q1 2019 in Review

49 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2019, worth a combined $138M — down 2.7% from $142M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TWST positions and 6 closed out — a net gain of 2 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.1M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $5.07M sold.

  • 49 institutional investors held Twist Bioscience (TWST) as of Q1 2019, up from 47 in Q4 2018.
  • Funds reported $138M of Twist Bioscience stock for Q1 2019, down 2.7% quarter-over-quarter.
  • 8 funds opened new Twist Bioscience positions in Q1 2019 and 6 closed out, a net change of +2 holders.
  • The largest Twist Bioscience buyer in Q1 2019 was JP Morgan Chase, an estimated $2.1M added.
  • The largest Twist Bioscience seller in Q1 2019 was Massachusetts Financial Services, an estimated $5.07M sold.

Based on aggregated 13F filings for Q1 2019.